Summary
- Current Price
- As of today, BCLI price is $0.70, unchanged in the most recent trading session on
- Current Price All-Time High
- BCLI price is currently -99.91% below its historical high of $787.50 set on
- Market Cap
- BCLI current market cap is $8M, down -20.40% year-over-year
- PE Ratio
- BCLI PE ratio is unknown
- Revenue
- BCLI current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for BCLI is on
Profile
| Metric | Value |
|---|---|
| Full Name | Brainstorm Cell Therapeutics Inc. |
| Ticker | NASDAQ: BCLI |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | brainstorm-cell.com |
| Employees | 29 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.70 | ||
| Price, 1D Change | 0.00% | |
| $8M | ||
| - | ||
| - | ||
| 0.79 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.31 | ||
| EPS, 1Y Change | +61.34% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:15 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.31 | ||
| EPS Estimate | -$1.61 | |
| EPS Est. Change | +30.44% | |
| $0.00 | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| $0.70 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.70 | -$5.99 | -755.24% | |
| -$2.10 | -$2.31 | -10.21% | |
| -$1.61 | N/A | +30.44% | |
| -$1.07 | N/A | +53.77% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -55.70% | ||
| -98.01% | ||
| -20.40% | ||
| -91.00% | ||
| 0.00% | ||
| 0.00% | ||
| +61.34% | ||
| +77.17% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $0.70 | ||
| $0.76 | ||
| SMA 200 vs Price | +9.17% | |
| $0.59 | ||
| SMA 50 vs Price | -16.00% | |
| 0.79 | ||
| $0.08 | ||
| 61.98 | ||
| 139.38% | ||
| 90.18% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$2.31 | ||
| -$240.00K | ||
| - | ||
| -$11.69M | ||
| - | ||
| -$11.62M | ||
| - | ||
| -$11.45M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -0.13 | ||
| 0.04 | ||
| 0.04 | ||
| - | ||
| - | ||
| -199.40 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| -1.00 | ||
| -0.76 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$7.76M | ||
| $187.00K | ||
| $1.83M | ||
| $385.00K | ||
| $9.60M | ||
| $8.98M | ||
| $1.02M | ||
| $849.00K | ||
| $6.08M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $11.62M | ||
| $11.45M | ||
| $240.00K | ||
| $0.00 | ||
| $240.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$9.09M | ||
| $12.00K | ||
| $7.97M | ||
| $0.00 | ||
| -$9.09M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Maxim Group | → | |
| Maxim Group | → | |
| Maxim Group | ||
| Maxim Group | → | |
| HC Wainwright & Co. | ||
| H.C. Wainwright | ||
| Maxim Group |
Analyst sentiment
Institutional ownership
Screeners with BCLI
FAQ
What is the ticker symbol for Brainstorm Cell Therapeutics Inc.?
The ticker symbol for Brainstorm Cell Therapeutics Inc. is NASDAQ:BCLI
Does Brainstorm Cell Therapeutics Inc. pay dividends?
No, Brainstorm Cell Therapeutics Inc. does not pay dividends
What sector is Brainstorm Cell Therapeutics Inc. in?
Brainstorm Cell Therapeutics Inc. is in the Healthcare sector
What industry is Brainstorm Cell Therapeutics Inc. in?
Brainstorm Cell Therapeutics Inc. is in the Biotechnology industry
What country is Brainstorm Cell Therapeutics Inc. based in?
Brainstorm Cell Therapeutics Inc. is headquartered in United States
When did Brainstorm Cell Therapeutics Inc. go public?
Brainstorm Cell Therapeutics Inc. initial public offering (IPO) was on October 7, 2003
Is Brainstorm Cell Therapeutics Inc. in the S&P 500?
No, Brainstorm Cell Therapeutics Inc. is not included in the S&P 500 index
Is Brainstorm Cell Therapeutics Inc. in the NASDAQ 100?
No, Brainstorm Cell Therapeutics Inc. is not included in the NASDAQ 100 index
Is Brainstorm Cell Therapeutics Inc. in the Dow Jones?
No, Brainstorm Cell Therapeutics Inc. is not included in the Dow Jones index
When was Brainstorm Cell Therapeutics Inc. last earnings report?
Brainstorm Cell Therapeutics Inc.'s most recent earnings report was on November 14, 2025
When does Brainstorm Cell Therapeutics Inc. report earnings?
The next expected earnings date for Brainstorm Cell Therapeutics Inc. is March 31, 2026
Data Sources & References
- BCLI Official Website www.brainstorm-cell.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1137883/000110465925112701/0001104659-25-112701-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1137883/000141057825000545/0001410578-25-000545-index.htm
- BCLI Profile on Yahoo Finance finance.yahoo.com/quote/BCLI
- BCLI Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bcli